Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.2559 | 0.2559 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.3823 | 0.3823 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0012 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3823 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.3823 | 0.3823 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0407 | 0.0407 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2559 | 0.2559 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2854 | 0.2854 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3823 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1721 | 0.4503 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0407 | 0.0407 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0012 | 0 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0407 | 0.0407 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2559 | 0.2559 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3823 | 1 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.3823 | 0.3823 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2559 | 0.2559 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0407 | 0.1064 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0407 | 0.0407 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0407 | 0.0407 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0407 | 0.0407 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.3823 | 0.3823 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0407 | 0.1064 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0407 | 0.0407 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3823 | 1 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0012 | 0 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0407 | 0.0407 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 1 | 1 |
Onchocerca volvulus | 0.0012 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1721 | 0.1721 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2559 | 0.2559 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2559 | 0.6693 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.2559 | 0.2559 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3823 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2854 | 0.2854 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.3823 | 0.3823 |
Echinococcus granulosus | muscleblind protein | 0.018 | 1 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.3823 | 0.3823 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0407 | 0.0407 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0407 | 0.1064 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2559 | 0.6693 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.3823 | 0.3823 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2854 | 0.2854 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0407 | 0.1064 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1721 | 0.1721 |
Brugia malayi | RNA binding protein | 0.0076 | 0.3823 | 0.3823 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0407 | 0.0407 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2559 | 0.6693 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2854 | 0.2854 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.2213 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 17.7828 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 26.8545 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.